Robert Benjamin Stein - May 15, 2023 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Role: President, Regenerative Med.
Signature: /s/ William F. Hulse as attorney in fact for Robert Benjamin Stein
Stock symbol: MDXG
Transactions as of: May 15, 2023
Transactions value $: -$83,798
Form type: 4
Date filed: 5/17/2023, 06:26 PM
Previous filing: May 12, 2023
Next filing: Mar 29, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDXG	Common Stock	Sale	-$22.2K	-3.61K	-1.09%	$6.15	328K	May 15, 2023	Direct	F1
transaction	MDXG	Common Stock	Sale	-$61.6K	-10.4K	-3.16%	$5.95	318K	May 16, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.
F2	The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.

Content

The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.

The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.